Ex Vivo Activity of Immunotherapeutic Approaches Targeting CD38 Against Daratumumab-Resistant Multiple Myeloma Patient Samples

被引：0
|
作者：
Karvouni, Maria [1 ]
Zhou, Heyue [2 ]
Kathleen, Arnika [1 ]
Ma, Qiangzhong [2 ]
Baloch, Alamdar H. [1 ]
Zhu, Tong [2 ]
Zhang, Hong [2 ]
Gilljam, Mari [3 ]
Lundqvist, Andreas [4 ]
Kaufmann, Gunnar F. [2 ]
Alici, Evren [1 ]
机构：
[1] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[2] Sorrento Therapeut Inc, San Diego, CA USA
[3] Karolinska Inst, Stockholm, Sweden
[4] Karolinska Inst, Dept Ocol Pathol, Stockholm, Sweden
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127893
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1848
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EX VIVO PHARMACOLOGICAL EVALUATION OF BORTEZOMIB IN MULTIPLE MYELOMA (MM) PATIENT SAMPLES
    Bennett, T.
    Primo, D.
    Hernandez, P.
    Vidal, L.
    Gorrochategui, J.
    Robles, A.
    Bosanquet, A.
    Martinez, J.
    Martin, E.
    Alarcon, C.
    Bailen, A.
    Cordoba, R.
    Moreno, M. J.
    Gonzalez, Y.
    Hernandez, J. M.
    Prosper, F.
    Orfao, A.
    Oriol, A.
    San Miguel, J.
    Ocio, E.
    Ballesteros, J.
    HAEMATOLOGICA, 2012, 97 : 107 - 108
  • [42] EXPRESSION LEVELS OF CD38 AND COMPLEMENT INHIBITORY PROTEINS CD55 AND CD59 PREDICT RESPONSE TO DARATUMUMAB IN MULTIPLE MYELOMA
    Nijhof, I.
    Axel, A.
    Casneuf, T.
    Mutis, T.
    Bloem, A.
    Van Velzen, J.
    Van Kessel, B.
    Minnema, M.
    Doshi, P.
    Lokhorst, H.
    Sasser, K.
    Van De Donk, N.
    HAEMATOLOGICA, 2015, 100 : 175 - 176
  • [43] Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab
    Nijhof, I. S.
    Groen, R. W. J.
    Lokhorst, H. M.
    van Kessel, B.
    Bloem, A. C.
    van Velzen, J.
    de Jong-Korlaar, R.
    Yuan, H.
    Noort, W. A.
    Klein, S. K.
    Martens, A. C. M.
    Doshi, P.
    Sasser, K.
    Mutis, T.
    van de Donk, N. W. C. J.
    LEUKEMIA, 2015, 29 (10) : 2039 - 2049
  • [44] CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy
    Pape, Luca Julius
    Hambach, Julia
    Gebhardt, Anna Josephine
    Rissiek, Bjoern
    Staehler, Tobias
    Tode, Natalie
    Khan, Cerusch
    Weisel, Katja
    Adam, Gerhard
    Koch-Nolte, Friedrich
    Bannas, Peter
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
    de Weers, Michel
    Tai, Yu-Tzu
    van der Veer, Michael S.
    Bakker, Joost M.
    Vink, Tom
    Jacobs, Danielle C. H.
    Oomen, Lukas A.
    Peipp, Matthias
    Valerius, Thomas
    Slootstra, Jerry W.
    Mutis, Tuna
    Bleeker, Wim K.
    Anderson, Kenneth C.
    Lokhorst, Henk M.
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (03): : 1840 - 1848
  • [46] CD38 antibody re-treatment in daratumumab-refractory multiple myeloma after time on other therapies
    de Acha, Olivia Perez
    Reiman, Lauren
    Jayabalan, David S.
    Walker, Zachary J.
    Bosma, Grace
    Keller, Alana L.
    Parzych, Sarah E.
    Abbott, Diana
    Idler, Beau M.
    Ribadeneyra, Drew
    Niesvizky, Ruben
    Forsberg, Peter A.
    Mark, Tomer M.
    Sherbenou, Daniel W.
    BLOOD ADVANCES, 2023, 7 (21) : 6430 - 6440
  • [47] Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab
    I S Nijhof
    R W J Groen
    H M Lokhorst
    B van Kessel
    A C Bloem
    J van Velzen
    R de Jong-Korlaar
    H Yuan
    W A Noort
    S K Klein
    A C M Martens
    P Doshi
    K Sasser
    T Mutis
    N W C J van de Donk
    Leukemia, 2015, 29 : 2039 - 2049
  • [48] EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA
    Costa, F.
    Toscani, D.
    Chillemi, A.
    Quarona, V.
    Bolzoni, M.
    Marchica, V.
    Vescovini, R.
    Mancini, C.
    Martella, E.
    Campanini, N.
    Schifano, C.
    Bonomini, S.
    Accardi, F.
    Horenstein, A. L.
    Aversa, F.
    Malavasi, F.
    Giuliani, N.
    HAEMATOLOGICA, 2017, 102 : 501 - 501
  • [49] Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Reverse Immunosuppression in Multiple Myeloma
    Feng, Xiaoyan
    Acharya, Chirag
    An, Gang
    Wen, Kenneth
    Zhang, Li
    Kalbasi, Alireza
    Qiu, Lugui
    Munshi, Nikhil C.
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    BLOOD, 2016, 128 (22)
  • [50] Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma
    Feng, Xiaoyan
    Zhang, Li
    Acharya, Chirag
    An, Gang
    Wen, Kenneth
    Qiu, Lugui
    Munshi, Nikhil C.
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4290 - 4300
12345